Navigation Links
InfoLogix Announces Approval for NASDAQ Listing
Date:9/24/2007

HATBORO, Pa., Sept. 24 /PRNewswire-FirstCall/ -- InfoLogix, Inc., a leading technology provider of mobile enterprise solutions for the healthcare and commercial industries, announced today that The NASDAQ Stock Market LLC has approved its application for listing of the Company's common stock on the NASDAQ Capital Market. Trading in the Company's common stock commenced on the morning of September 24, 2007 under the symbol "IFLG."

(Logo: http://www.newscom.com/cgi-bin/prnh/20060209/PHTH052LOGO )

"We are extremely pleased that our listing application has been approved. This listing is a significant milestone for our company and highlights our continuing commitment to enhancing shareholder value," commented David Gulian, president and CEO of InfoLogix, Inc. "The move to the NASDAQ Capital Market will not only increase our visibility and credibility in the marketplace but also enhance liquidity and trading efficiency for investors. We are proud to have satisfied the standards of reporting and financial strength required by NASDAQ."

InfoLogix provides RFID and other technology solutions for the healthcare and enterprise mobility markets, including solutions that directly address three of the top four technology needs identified by CIOs in the 18th annual HIMSS leadership survey. The global RFID marketplace is expected to exceed $26 billion by 2015 according to industry analysts. InfoLogix provides various technology solutions to over 1,400 hospitals, or 20% of all hospitals located in the United States.

About InfoLogix, Inc.

InfoLogix (Nasdaq: IFLG) is a leading provider of technology and RFID based intelligence solutions that enable the mobile enterprise. InfoLogix uses the industry's most advanced technologies to increase the efficiency, accuracy, and transparency of complex business and clinical processes for the healthcare industry and the commercial marketplace. With 19 issued patents, InfoLogix provides mobile managed solutions, on-demand software applications, mobile infrastructure products, and strategic consulting services to over 2,000 clients in North America including Kraft Foods, Merck and Company, General Electric, News America Corporation, Mercedes Benz, Kaiser Permanente, Adventist Health, Universal Health Services, and Stanford School of Medicine. Founded in 2001 and headquartered in suburban Philadelphia, PA, InfoLogix has been named the sixth fastest growing new business in the United States for the last three years by Entrepreneur Magazine. For more information, visit http://www.infologixsys.com.

Safe Harbor Statement

This press release contains forward looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and that represent our expectations or beliefs about future events and financial performance. Forward-looking statements are identifiable by words such as "believe," "anticipate," "expect," "intend," "plan," "will," "may" and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Forward-looking statements are subject to known and unknown risks and uncertainties, including those described in our Annual Report on Form 10-K for the year ended December 31, 2006 and other filings we make with the Securities and Exchange Commission. Actual results could differ materially from those suggested by the forward- looking statements. We do not make any commitment to revise or update any forward-looking statements to reflect new information events or circumstances occurring or existing after the date of any forward-looking statement is made.


'/>"/>
SOURCE InfoLogix, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. InfoLogix, Inc. the Leading Healthcare Technology Company SaysHealthcare Informatics
2. PM announces a new health care order for India
3. Ramdoss Announces Introduction of RCH-II
4. Britain Announces Third Transfusion Related Mad Cow Case
5. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
6. Tibet Announces the Dalai Lama’s Tour of South Americ
7. NHS announces further Cost cutting Measures
8. Indian PM Announces Of Setting Up India Study Center At Tashkent
9. PowderMed Announces Needle-Less Flu Vaccine
10. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
11. Australian Government Announces Survey To Tackle Childhood Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Francisco, CA (PRWEB) , ... March 28, 2017 , ... ... people suffering from acne, access to quality care can be limited while the desire ... company that offers customized prescription acne care for every customer online, today released its ...
(Date:3/28/2017)... ... March 28, 2017 , ... A minimally invasive porcelain ... smile.” The National Association of Dental Laboratories (NADL) is informing dentists about the ... of when utilizing dental laboratories and technicians that create these veneers. , ...
(Date:3/28/2017)... ... March 28, 2017 , ... With expansion and efficiency in mind, Patten ... , The seed processing plant opened in Marshallville in 2006, and a bagging and ... allows opportunity for transition of Patten Seed operations to the Middle Georgia location from ...
(Date:3/28/2017)... ... , ... “A Prophets Bones”: a thrilling adventure that reveals the mystery of Kevin’s purpose. “A ... his parents and teachers had asked of him that he had neglected to do, but ... the Almighty Creator. There were some who would have felt themselves to be special and ...
(Date:3/27/2017)... , ... March 27, 2017 , ... New patients who ... replace their missing teeth can now have them placed by Dr. Manju Kejriwal, with ... i-CAT® Cone Beam technology to increase the accuracy of each dental implant placement. The ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... Office (JPO) for the composition of matter of ... the treatment or prevention of fibrotic disorders, including ... retinopathy (Japanese Patent #: 6060071).  This patent includes ...
(Date:3/28/2017)... SAN FRANCISCO , March 28, 2017 ... is expected to reach USD 8.0 billion by 2025, ... Inc. The increasing incidence of infectious diseases and cancer ... for use in disease diagnosis over the coming years. ... the usage of autologous and allogenic stem cell therapy, ...
(Date:3/28/2017)... , March 28, 2017 Elysium ... with Cambridge academic ...   The Milner Therapeutics Institute today announces Elysium ... Health has committed significant investment for collaborative projects with academic ... four years. This is the first major research investment outside ...
Breaking Medicine Technology: